PhD in Bioprocess Chemistry: Therapeutic Nucleoside Editing

RFCSR; Manchester; On-site; GBP 18,000 - 28,000; Full time

Benefits offered by this job

Stipend

Job summary

The University of Manchester’s School of Chemistry invites applications for a fully funded PhD studentship in Bioprocess: Skeletal Editing of Therapeutic Nucleosides.

This 3.5-year programme starts in 2026 and focuses on developing bioprocess strategies and skeletal editing to create novel therapeutic nucleosides, integrating synthesis, analytics, and biocatalysis within a collaborative research environment.

Qualifications

• Ideal candidates will have substantial laboratory experience in organic chemistry, including familiarity with chemical synthesis, reaction optimisation, and analytical characterisation techniques.
• Ability to think independently, work collaboratively in a research team, and engage with complex scientific problems is essential.

Responsibilities

• Develop bioprocess strategies and skeletal editing methodologies for novel nucleoside structures.
• Collaborate with faculty to advance drug discovery and bioprocess development.
• Apply cutting-edge synthesis, analytical methods, and biocatalytic processes.

Skills

Laboratory experience in organic

Synthesis

Reaction optimisation

Analytical characterisation

Independent thinking

Education

First-class honours degree in chemistry

Tools

Analytical techniques

Job description

The University of Manchester’s School of Chemistry invites applications for a fully funded PhD studentship in Bioprocess: Skeletal Editing of Therapeutic Nucleosides.

This 3.5-year programme starts in 2026 and focuses on developing bioprocess strategies and skeletal editing to create novel therapeutic nucleosides, integrating synthesis, analytics, and biocatalysis within a collaborative research environment.